PharVision Advisers’s BellRing Brands BRBR Stock Holding History

PharVision Advisers’s Portfolio BRBR Stock Details BRBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,474	Closed	-$408K	–	287
2025 Q1	$408K	Buy	+5,474	New	+$402K	0.57%	30

Other funds holding BRBR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PharVision Advisers's BRBR Position: Q2 2025 in Review

PharVision Advisers sold out of BellRing Brands (BRBR) in Q2 2025, closing a stake of 5,474 shares — an estimated $408K sold.

PharVision Advisers first reported a position in BRBR in Q1 2025 and held it in 1 quarter. The position peaked at $408K in Q1 2025. 485 funds tracked by Wall St. Rank hold BRBR as of Q2 2025.

PharVision Advisers reported no remaining BellRing Brands position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 5,474 BellRing Brands shares in Q2 2025, an estimated $408K.
PharVision Advisers first reported a position in BellRing Brands in Q1 2025 and held it in 1 quarter.
PharVision Advisers's BellRing Brands position peaked at $408K in Q1 2025.
485 funds tracked by Wall St. Rank held BellRing Brands as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.